| BURU 0.3705 31.80% | CTNT 0.0331 -17.25% | TZA 5.09 0.99% | SOXS 15.7 -6.55% | NOK 10.32 4.67% | PAPL 0.87 44.90% | TSLL 12.02 -7.04% | INTC 66.78 2.31% | QS 7.41 1.37% | BITO 10.68 -1.29% | NVDA 199.64 -1.41% | BYND 0.9501 -13.63% | SOXL 112.77 6.75% | TSLA 373.72 -3.56% | TQQQ 59.22 -1.64% | SPDN 9.15 0.44% | BMNG 1.46 -10.98% | AUUD 5.06 30.75% | AIXI 1.08 20.70% | AAL 11.78 2.43% | MEHA 0.1035 -19.77% | NVD 5.72 2.88% | SQQQ 55.66 1.70% | PLUG 3.18 -0.31% | MWYN 0.7 23.02% | SMR 12.715 -6.30% | KEEL 3.24 6.58% | PLTR 141.57 -7.24% | IREN 52.02 7.50% | CGC 1.22 -11.59% | NVTS 18.51 0.22% | MSOS 4.22 -17.42% | SPY 708.45 -0.39% | CPIX 3.9 27.87% | ONDS 10.54 -4.70% | APLD 36.35 12.09% | SOFI 18.32 -3.88% | CMCSA 31.64 7.73% | SMCI 26.75 -8.33% | POET 11.72 -8.22% | SCO 7.17 -4.91% | HIMS 28.15 -2.95% | XLF 51.8 -0.79% | SNAP 5.57 -4.62% | MARA 11.8 -0.34% | TLRY 6.94 -11.82% | AMD 305.33 0.62% | GRAB 3.96 -2.46% | OPEN 5.22 -3.87% | KWEB 28.43 -2.74%

Chemung Financial Corp (NASDAQ:CHMG) Reports Strong Fourth-Quarter Earnings

Chemung Financial Corp (NASDAQ:CHMG), a key player in the Zacks Banks - Southeast industry, has recently made headlines with its strong financial performance in the fourth quarter. The company, operating through its subsidiary, Chemung Canal Trust Company, has shown a remarkable ability to exceed market expectations.

On February 2, 2026, Tyrrell Thomas R., a director at Chemung Financial, sold 500 shares of the company's common stock at $61 each, retaining around 8,800 shares post-transaction. This move came shortly after the company announced its fourth-quarter earnings, which were slightly above the Zacks Consensus Estimate with an EPS of $1.61, compared to last year's $1.24 EPS for the same quarter. The earnings surprise of +0.63% underscores the company's operational efficiency and market foresight.

Revenue figures were also impressive, with Chemung Financial posting $30.59 million for the quarter ending December 2025, a significant increase from the $25.88 million reported in the previous year. This 5.11% beat against the Zacks Consensus Estimate marks a notable achievement, although it's important to note that the company has only exceeded consensus revenue estimates once in the last four quarters.

The company's net income for the fourth quarter stood at $7.7 million, or $1.61 per share, showcasing a steady performance despite a slight decrease from the third quarter's $7.8 million, or $1.62 per share. Yearly figures were also strong, with a net income of $15.1 million, or $3.14 per share, which includes a significant $17.5 million loss on the sale of securities.

Chemung Financial's valuation and profitability metrics, such as a P/E ratio of approximately 19.93, a price-to-sales ratio of about 2.25, and an enterprise value to sales ratio of around 2.08, offer investors a comprehensive view of the company's financial health. The enterprise value to operating cash flow ratio stands at approximately 7.83, with an earnings yield of about 5.02%, further highlighting the company's robust financial standing.

Published on: February 2, 2026